rs1803274

This is a variant in the BCHE gene that changes a alanine to an threonine.

GWAS Catalog Trait Associations (9)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

butyrylcholinesterase measurement

Allele T
OR 0.71
p 6.0e-262
N 6,879
Large GWAS
European
Allele T
OR 0.36
p 6.0e-92
N 11,683
Large GWAS
European

dynactin subunit 2 measurement

Pietzner M et al. Mapping the proteo-genomic convergence of human diseases. Science (new York, N.y.) 374(6569):eabj1541 (2021)
Allele T
OR 0.15
p 5.0e-18
N 10,708
Large GWAS
European

apolipoprotein M measurement

Sun BB et al. Genomic atlas of the human plasma proteome. Nature 558(7708):73-79 (2018)
Allele T
OR 0.24
p 3.0e-15
N 3,301
Large GWAS
European

alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 measurement

Pietzner M et al. Mapping the proteo-genomic convergence of human diseases. Science (new York, N.y.) 374(6569):eabj1541 (2021)
Allele T
OR 0.14
p 9.0e-15
N 10,708
Large GWAS
European

serine/threonine-protein kinase ULK3 measurement

Pietzner M et al. Mapping the proteo-genomic convergence of human diseases. Science (new York, N.y.) 374(6569):eabj1541 (2021)
Allele T
OR 0.13
p 3.0e-13
N 10,708
Large GWAS
European

histone-lysine N-methyltransferase SETD2 measurement

Pietzner M et al. Mapping the proteo-genomic convergence of human diseases. Science (new York, N.y.) 374(6569):eabj1541 (2021)
Allele T
OR 0.12
p 5.0e-13
N 10,708
Large GWAS
European

poly(A) RNA polymerase, mitochondrial measurement

Pietzner M et al. Mapping the proteo-genomic convergence of human diseases. Science (new York, N.y.) 374(6569):eabj1541 (2021)
Allele T
OR 0.12
p 2.0e-12
N 10,708
Large GWAS
European

tumor necrosis factor ligand superfamily member 14 measurement

Pietzner M et al. Mapping the proteo-genomic convergence of human diseases. Science (new York, N.y.) 374(6569):eabj1541 (2021)
Allele T
OR 0.12
p 3.0e-12
N 10,708
Large GWAS
European

protein measurement

Pietzner M et al. Mapping the proteo-genomic convergence of human diseases. Science (new York, N.y.) 374(6569):eabj1541 (2021)
Allele T
OR 0.13
p 3.0e-14
N 10,708
Large GWAS
European

ClinVar annotation

Pathogenic☆☆☆
8 submitters8 publications

Butyrylcholinesterase activity; Deficiency of butyrylcholinesterase (BCHED); not specified

View on ClinVar →

Research that mentions this SNP (2)

Variability of the BCHE gene in Amerindians from Paraná, Brazil
AssociationN=240Hugo Silva‐Alves et al.(2011)· American Journal of Human Biology

This study examined BCHE gene variability in two Amerindian populations (Kaingang and Guarani-Mbya from Brazil) by analyzing seven SNPs (two upstream, three within, two downstream of BCHE). Amerindians showed lower BCHE variant frequencies than other populations. Key findings included absence of the 116A variant (rs1126680) in Amerindians, presence of the K allele (539T, rs1803274), and three SNPs (rs3495, rs7624915, rs4387996) showing ancestral allele frequency patterns decreasing from Africa toward the Americas. Despite geographical proximity, Kaingang and Guarani retained >90% ancestral genetic constitution, demonstrating cultural and social isolation maintained genetic identity.

Traits studied:BCHE gene variabilityGenetic diversity
Variability of AChE, BChE, and ChAT genes in the late‐onset form of Alzheimer's disease and relationships with response to treatment with Donepezil and Rivastigmine
AssociationN=725Renato Scacchi et al.(2009)· American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

This case-control study examined four SNPs in cholinergic system genes (AChE rs2571598, BChE rs1355534, BChE rs1803274, and ChAT rs2177369) in 471 late-onset Alzheimer's disease (LOAD) patients and 254 controls from Northern Italy. Only ChAT rs2177369 showed a significant association with AD onset, with the G/G genotype conferring increased risk (OR = 1.56; 95% CI 1.10-2.22; P = 0.01). Among treated patients (n=171), no consistent associations between SNP genotypes and response to Donepezil or Rivastigmine were observed, though the AChE rs2571598 A/A genotype showed a trend toward better response to Rivastigmine.

Traits studied:Alzheimer's diseaseCognitive decline in response to Donepezil treatmentCognitive decline in response to Rivastigmine treatmentLate-onset Alzheimer's disease (LOAD)

About BCHE

This gene encodes a cholinesterase enzyme and member of the type-B carboxylesterase/lipase family of proteins. The encoded enzyme exhibits broad substrate specificity and is involved in the detoxification of poisons including organophosphate nerve agents and pesticides, and the metabolism of drugs including cocaine, heroin and aspirin. Humans homozygous for certain mutations in this gene exhibit prolonged apnea after administration of the muscle relaxant succinylcholine. [provided by RefSeq, Jul 2016]

View all BCHE variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…